For CoCNV, some genes in the PMI network gene set can classify patients into groups with significantly different survival probability by their single gene CNV, such as CTLA4, ORM1, and RASAL3 in triple negative breast cancer. The gene discussed is ORM1; the disease is triple-negative breast carcinoma.